Ruff Shamim Insider Trades

Insider Trading History

Track insider trading activity for Ruff Shamim. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $0 0 shares
Last Trade
Sep 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.59M 15,015 shares
$172.36
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $2.69M 15,594 shares
Last Trade
Jul 28, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.38M 8,235 shares
$167.19
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $575k 3,334 shares
Last Trade
Jul 28, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.17M 6,985 shares
$167.19
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $1.27M 7,359 shares
Last Trade
Jul 28, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.35M 8,235 shares
$164.53
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $1.27M 7,359 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$454k 4,849 shares
$93.61
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $242k 1,405 shares
Last Trade
Mar 10, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$476k 5,740 shares
$82.96
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $1.89M 10,963 shares
Last Trade
Mar 10, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$476k 5,740 shares
$82.96
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $900k 5,223 shares
Last Trade
Mar 10, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$481k 5,740 shares
$83.73
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $969k 5,620 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$477k 14,263 shares
$33.43
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $34.3k 199 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.66k 317 shares
$27.32
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $862k 5,000 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$844k 5,780 shares
$146.01
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $55k 319 shares
Last Trade
Apr 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.4k 319 shares
$92.20
$172.36
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp, Chief Regulatory Affairs
Holding Value $519k 31,936 shares
Last Trade
May 22, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$116k 1,305 shares
$89.22
$16.24
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp, Chief Regulatory Affairs
Holding Value $0 0 shares
Last Trade
May 22, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$395k 4,432 shares
$89.22
$16.24
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp, Chief Regulatory Affairs
Holding Value $540k 33,241 shares
Last Trade
May 22, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$395k 4,432 shares
$89.22
$16.24
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp, Chief Regulatory Affairs
Holding Value $163k 10,066 shares
Last Trade
Mar 15, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$203k 2,500 shares
$81.22
$16.24
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp, Chief Regulatory Affairs
Holding Value $468k 28,809 shares
Last Trade
Mar 15, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$59.8k 736 shares
$81.22
$16.24
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp, Chief Regulatory Affairs
Holding Value $479k 29,465 shares
Last Trade
Mar 15, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$203k 2,500 shares
$81.22
$16.24
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp, Chief Regulatory Affairs
Holding Value $1.14M 70,000 shares
Last Trade
Mar 05, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5M 70,000 shares
$71.45
$16.24
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp, Regulatory Affairs & Qual
Holding Value $602k 37,045 shares
Last Trade
Nov 06, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$555k 10,000 shares
$55.52
$16.24

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up